Literature DB >> 30694374

Adolescent exposure to Δ9-tetrahydrocannabinol delays acquisition of paired-associates learning in adulthood.

Andrew R Abela1,2,3, Arya Rahbarnia4,5, Suzanne Wood5, Anh D Lê4,6, Paul J Fletcher4,7,5.   

Abstract

RATIONALE AND
OBJECTIVES: Adolescence is a sensitive period of brain development, during which there may be a heightened vulnerability to the effects of drug use. Despite this, the long-term effects of cannabis use during this developmental period on cognition are poorly understood.
METHODS: We exposed adolescent rats to escalating doses of Δ9-tetrahydrocannabinol (THC)-the primary psychoactive component of cannabis-or vehicle solution during postnatal days (PND) 35-45, a period of development that is analogous to human adolescence (THC doses: PND 35-37, 2.5 mg/kg; PND 38-41, 5 mg/kg; PND 42-45, 10 mg/kg). After a period of abstinence, in adulthood, rats were tested on an automated touchscreen version of a paired-associates learning (PAL) task to assess their ability to learn and recall object-location associations. Prepulse inhibition (PPI) of the startle response was also measured at three time points (5 days, 4 months, and 6 months after exposure) to assess sensorimotor gating, the ability to filter out insignificant sensory information from the environment.
RESULTS: Compared to rats exposed to vehicle alone, rats exposed to THC during adolescence took longer to learn the PAL task when tested in adulthood, even when trials contained visually identical stimuli that differed only in location. Despite this, no differences were observed later in testing, when trials contained visually distinct stimuli in different locations. Rats exposed to THC also displayed impairments in sensorimotor gating, as measured by prepulse inhibition of the startle response, though this deficit did appear to decrease over time.
CONCLUSION: Taken together, THC exposure during adolescence produces long-term deficits in associative learning and sensorimotor gating, though the impact of these deficits seems to diminish with time. Thus, adolescence may represent a period of neurocognitive development that is vulnerable to the harms of cannabis use, though the stability of such harms is uncertain.

Entities:  

Keywords:  Adolescence; Cognition; Paired-associates learning; Prepulse inhibition; Δ9-Tetrahydrocannabinol (THC)

Mesh:

Substances:

Year:  2019        PMID: 30694374     DOI: 10.1007/s00213-019-5171-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  53 in total

Review 1.  The adolescent brain and age-related behavioral manifestations.

Authors:  L P Spear
Journal:  Neurosci Biobehav Rev       Date:  2000-06       Impact factor: 8.989

Review 2.  Trajectories of brain development: point of vulnerability or window of opportunity?

Authors:  Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

3.  Early-onset cannabis use and cognitive deficits: what is the nature of the association?

Authors:  Harrison G Pope; Amanda J Gruber; James I Hudson; Geoffrey Cohane; Marilyn A Huestis; Deborah Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492

4.  Specific attentional dysfunction in adults following early start of cannabis use.

Authors:  H Ehrenreich; T Rinn; H J Kunert; M R Moeller; W Poser; L Schilling; G Gigerenzer; M R Hoehe
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

5.  Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania.

Authors:  W Perry; A Minassian; D Feifel; D L Braff
Journal:  Biol Psychiatry       Date:  2001-09-15       Impact factor: 13.382

6.  Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia.

Authors:  D L Braff; M A Geyer; G A Light; J Sprock; W Perry; K S Cadenhead; N R Swerdlow
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

7.  Cognitive functioning of long-term heavy cannabis users seeking treatment.

Authors:  Nadia Solowij; Robert S Stephens; Roger A Roffman; Thomas Babor; Ronald Kadden; Michael Miller; Kenneth Christiansen; Bonnie McRee; Janice Vendetti
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

8.  Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.

Authors:  Miriam Schneider; Michael Koch
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

9.  Residual learning deficit after heavy exposure to cannabis or alcohol in rats.

Authors:  K A Fehr; H Kalant; A E LeBlanc
Journal:  Science       Date:  1976-06-18       Impact factor: 47.728

Review 10.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.

Authors:  D Rice; S Barone
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

View more
  4 in total

1.  Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome.

Authors:  Jacqueline-Marie N Ferland; Randall J Ellis; Gregory Rompala; Joseph A Landry; James E Callens; Annie Ly; Micah D Frier; Teddy O Uzamere; Yasmin L Hurd
Journal:  Mol Psychiatry       Date:  2022-03-02       Impact factor: 15.992

Review 2.  Cannabis and synaptic reprogramming of the developing brain.

Authors:  Anissa Bara; Jacqueline-Marie N Ferland; Gregory Rompala; Henrietta Szutorisz; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2021-05-21       Impact factor: 38.755

Review 3.  Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition.

Authors:  Erica Zamberletti; Tiziana Rubino
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

4.  Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats.

Authors:  Christina M Ruiz; Alexa Torrens; Erik Castillo; Christina R Perrone; Jenny Cevallos; Victoria C Inshishian; Eden V Harder; Drew N Justeson; Marilyn A Huestis; Vivek Swarup; Daniele Piomelli; Stephen V Mahler
Journal:  Neuropsychopharmacology       Date:  2020-09-14       Impact factor: 7.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.